Financial results - MEDICAT MEDFAM SRL

Financial Summary - Medicat Medfam Srl
Unique identification code: 29530625
Registration number: J28/14/2012
Nace: 8622
Sales - Ron
81.291
Net Profit - Ron
30.193
Employee
2
The most important financial indicators for the company Medicat Medfam Srl - Unique Identification Number 29530625: sales in 2023 was 81.291 euro, registering a net profit of 30.193 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Medicat Medfam Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 38.367 43.105 45.847 49.890 73.749 90.475 71.997 91.932 94.335 81.291
Total Income - EUR 38.368 43.472 45.847 49.890 81.057 90.705 71.999 91.934 94.336 81.292
Total Expenses - EUR 36.199 39.628 47.846 45.999 61.245 71.115 58.420 53.598 63.810 49.675
Gross Profit/Loss - EUR 2.168 3.844 -1.999 3.891 19.812 19.590 13.579 38.335 30.526 31.618
Net Profit/Loss - EUR 1.017 2.540 -2.457 3.393 19.001 18.683 12.911 37.434 29.602 30.193
Employees 4 4 4 5 4 4 3 3 3 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -13.6%, from 94.335 euro in the year 2022, to 81.291 euro in 2023. The Net Profit increased by 681 euro, from 29.602 euro in 2022, to 30.193 in the last year.

Check the financial reports for the company - Medicat Medfam Srl

Rating financiar

Financial Rating -
Medicat Medfam Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Medicat Medfam Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Medicat Medfam Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Medicat Medfam Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Medicat Medfam Srl - CUI 29530625

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 18.395 13.667 7.510 2.918 22.869 17.575 10.638 3.699 639 1.986
Current Assets 6.801 2.988 3.722 4.377 17.341 28.300 10.916 7.776 34.023 29.104
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 2.106 1.954 3.415 3.610 5.567 5.538 75 7.448 22.709 23.257
Cash 4.696 1.034 306 767 11.775 22.763 10.840 328 11.314 5.848
Shareholders Funds 6.219 8.810 -2.413 1.021 20.003 38.299 15.665 6.202 29.650 30.242
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 18.978 7.845 13.645 6.274 20.207 7.577 5.888 5.272 5.012 849
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 29.104 euro in 2023 which includes Inventories of 0 euro, Receivables of 23.257 euro and cash availability of 5.848 euro.
The company's Equity was valued at 30.242 euro, while total Liabilities amounted to 849 euro. Equity increased by 681 euro, from 29.650 euro in 2022, to 30.242 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Medicat Medfam Srl

Comments - Medicat Medfam Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.